Skip to main content
. 2021 Aug 9;20(17):1681–1691. doi: 10.1080/15384101.2021.1958502

Figure 1.

Figure 1.

Expression pattern and prognostic implication of DTYMK in HCC

(a) DTYMK mRNA expression between HCC and normal hepatic tissues in TCGA-LIHC cohort; (b) DTYMK mRNA expression between HCC and normal hepatic tissues in ICGC-LIRI-JP cohort; (c) DTYMK mRNA expression between HCC and normal hepatic tissues in GSE14520 cohort; (d) DTYMK mRNA expression between HCC and normal hepatic tissues in GSE54236 cohort; (e) DTYMK mRNA expression between HCC and normal hepatic tissues in GSE63898 cohort; (f) DTYMK mRNA expression between stage I+ II HCC and stage III+IV HCC samples in TCGA-LIHC cohort; (g) DTYMK mRNA expression between stage I+ II HCC and stage III+IV HCC samples in ICGC-LIRI-JP cohort; (h) DTYMK mRNA expression between HCC without portal vein invasion and HCC with portal vein invasion samples in ICGC-LIRI-JP cohort; (i) DTYMK mRNA expression between HCC without vascular invasion and HCC with vascular invasion samples in ICGC-LIRI-JP cohort; (j) DTYMK mRNA expression between fibrosis grade F0-2 HCC and fibrosis grade F3-4 HCC samples in ICGC-LIRI-JP cohort; (k) tumor doubling time between high DTYMK mRNA expression samples and low DTYMK mRNA expression samples in GSE54326 cohort; (l) Kaplan-Meier curve of overall survival for DTYMK expression in ICGC-LIRI-JP cohort; (M) Kaplan-Meier curve of overall survival for DTYMK expression in TCGA-LIHC cohort; (N) Kaplan-Meier curve of overall survival for DTYMK expression in Kaplan-Meier Plotter; (o) Kaplan-Meier curve of recurrence free survival for DTYMK expression in Kaplan-Meier Plotter; (p) Kaplan-Meier curve of disease specific survival for DTYMK expression in Kaplan-Meier Plotter.